RecruitingNot ApplicableNCT06887231

Virtual Reality and Neurostimulation for Early Stroke Rehabilitation

Virtual Reality (VR) Platform and Transcutaneous Electrical Nerve Stimulation (TENS) for Early Stroke Rehabilitation


Sponsor

Medical University of Vienna

Enrollment

35 participants

Start Date

Mar 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Stroke is one of the leading causes of disability, leaving millions of individuals each year impaired with lasting motor and sensory impairments. In the subacute phase, which goes from the first week to 3 months post-stroke, the patient has the highest recovery, which could be boosted by proper technologies intended for the rehabilitation of the patients. The impairments that the patients experience are extremely heterogeneous and go from muscle weakness to spasticity of the paretic side of the body. Beyond motor deficits, stroke survivors also suffer from sensory impairment (they do not properly feel with the paretic side of their body), impaired body representation (misjudging the size, position, and movement of their affected limb), which can further hinder recovery. Traditional rehabilitation primarily targets motor function, often without considering at all the role of sensory feedback and body perception in the recovery process. However, growing evidence suggests that the combination of multiple sensory modalities towards a multifaceted rehabilitation can enhance neuroplasticity and improve rehabilitation outcomes. To address this, the investigators have developed a novel rehabilitation approach that integrates immersive virtual reality (VR) with transcutaneous electrical nerve stimulation (TENS). This system allows stroke patients to interact with a virtual environment while receiving synchronized tactile stimulation, reinforcing sensorimotor integration. Unlike conventional therapy, which relies on passive or repetitive exercises, this approach engages patients in active, goal-oriented movements, tailored to their individual recovery progress. By focusing on the subacute stroke population, this project aims to leverage the brain's heightened plasticity during early recovery to maximize functional improvements. The VR-based intervention will adapt to each patient's motor abilities, providing real-time feedback to encourage precise movements and enhance sensory processing. Through this multisensory experience, the investigators seek to improve not only motor control but also sensory and body representation measures.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria5

  • Confirmed diagnosis of ischemic or hemorrhagic stroke
  • In the subacute phase (from 7 days to 3 months from last stroke onset)
  • Fugl-Meyer-Upper Extremity (FMUE) scale for the motor part: FMUE ≥ 10
  • Ability to sit in an upright position
  • Age between 18 and 80 years

Exclusion Criteria6

  • Other neurological or physical impairment or mental condition that, in the judgment of the investigator, does not allow participation in the study.
  • Mini-Mental State Examination (MMSE) < 24
  • Epilepsy
  • Nausea, headaches or fatigue due to VR-generated environment ("virtual reality motion sickness")
  • Peripheral nerve damage in the affected arm or hand
  • Pacemaker or other electronic implants

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVR+TENS

Patients will perform task-oriented movements in an immersive scenario while receiving congruent electrical stimulation. During each session, multiple games will be played, with the type and difficulty calibrated based on the patient's level of impairment.

OTHERConventional rehabilitation

Patients will perform dose-matched conventional rehabilitation (aligned with the intervention group), which will include physiotherapy, occupational therapy, and physical therapy.


Locations(1)

Medical University of Vienna, Department of Neurology

Vienna, State of Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06887231


Related Trials